小打小闹心平气和的个人主页 - 老虎社区

小打小闹心平气和

小打小闹心平气和

暂无个人介绍

IP属地：未知

6关注

3粉丝

0主题

0勋章

小打小闹心平气和

04-30

$迈威生物-B(02493)$医药股蹲的就是管线的兑现。2821任何一个适应症报产，都是股价双击。我选择提前蹲，不等跑起来再追

小打小闹心平气和

01-09

$极智嘉-W(02590)$ 基石长期持有+入港股通，近期订单也是不断，入通前能上30

小打小闹心平气和

09-22

我思路跟大伙不太一样，发布会、技术参数我都懒得细扒。我就看价格。早先800V高压，基本二十万起步。现在银河十几万就能拿下。这就好比以前高档餐厅的招牌菜，如今放到家常菜馆卖$吉利汽车(00175)$

小打小闹心平气和

2025-11-17

$赛力斯(601127)$ 销量增长、新车型落地、技术合作落地三利好叠加，赛力斯的新车型周期和具身智能业务布局形成了良性呼应

小打小闹心平气和

06-09

多款产品都在开拓海外市场，业务路子越走越宽，对长期发展是好事。$迈威生物-B(02493)$

@财小灶:迈威生物全球首个清除型抗体获批临床，用于治疗炎症性肠病（IBD）

小打小闹心平气和

04-30

$思格新能(06656)$ 思格新能源上市才半个月，机构锁仓多，现在回调是洗盘，坚定看多，看到 750

小打小闹心平气和

04-22

$思格新能(06656)$ 分布式储能全球第一，市占率28.6%，思格新能源这是把细分赛道做到极致了，龙头溢价必须给

小打小闹心平气和

03-18

$山高控股(00412)$不懂为什么那么多人去追那些几百倍市盈率的氢能概念股。山高实打实投了好几个大的光伏电站和储能项目，现金流都是看得见的。按照机构给的可比公司估值，比如长江电力或者龙源电力那种逻辑，山高目前的市值远远没反映它手里的绿电资产。把它拆开卖都不止这个价。

小打小闹心平气和

02-24

$MINIMAX-WP(00100)$ 中国AI行业从200多家卷到不到10家，MiniMax能活下来还被小摩增持，肯定有自己的硬实力。小摩说“MiniMax这么便宜，必须买进”，外界再怎么说，它在模型性能和商业化上的进展，都是实打实的

小打小闹心平气和

02-03

$明略科技-W(02718)$ 明略股价走势一路向上，看来资金都看好GEO这个AI营销新赛道的潜力

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4215313328797350","uuid":"4215313328797350","gmtCreate":1752210141170,"gmtModify":1752210878272,"name":"小打小闹心平气和","pinyin":"xdxnxpqhxiaodaxiaonaoxinpingqihe","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":6,"tweetSize":23,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":610428710101032,"gmtCreate":1790057211699,"gmtModify":1790057213980,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"我思路跟大伙不太一样，发布会、技术参数我都懒得细扒。我就看价格。早先800V高压，基本二十万起步。现在银河十几万就能拿下。这就好比以前高档餐厅的招牌菜，如今放到家常菜馆卖<a href=\"https://laohu8.com/S/00175\">$吉利汽车(00175)$</a>","listText":"我思路跟大伙不太一样，发布会、技术参数我都懒得细扒。我就看价格。早先800V高压，基本二十万起步。现在银河十几万就能拿下。这就好比以前高档餐厅的招牌菜，如今放到家常菜馆卖<a href=\"https://laohu8.com/S/00175\">$吉利汽车(00175)$</a>","text":"我思路跟大伙不太一样，发布会、技术参数我都懒得细扒。我就看价格。早先800V高压，基本二十万起步。现在银河十几万就能拿下。这就好比以前高档餐厅的招牌菜，如今放到家常菜馆卖$吉利汽车(00175)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/610428710101032","isVote":1,"tweetType":1,"viewCount":1199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606112229249912,"gmtCreate":1789013604230,"gmtModify":1789013606316,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"配置内卷，安全确实重要","listText":"配置内卷，安全确实重要","text":"配置内卷，安全确实重要","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606112229249912","repostId":"606092755162496","repostType":1,"repost":{"id":606092755162496,"gmtCreate":1789008921212,"gmtModify":1789010657249,"author":{"id":"4142472227465700","authorId":"4142472227465700","name":"港股老斯基","avatar":"https://static.tigerbbs.com/eab4b3f8d73838037b36ea737c07fa3f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4142472227465700","idStr":"4142472227465700"},"themes":[],"title":"量价齐稳的背后，赛力斯做对了什么？","htmlText":"金九银十的车市向来热闹，今年这份捷报值得一看——全新一代问界M9开启交付仅12周，累计交付突破30000台。 终端均价稳在60万元，持续位居50万级乘用车销量榜首。量价双优，放在当下的消费环境里，这个表现不算常见。 12周3万台，均价60万意味着什么？ 先看一组对比。问界M6累计交付突破5万台，售价22.98万元起；全新问界M9均价60万，12周破3万。一个往下扎，一个往上攻。赛力斯这套组合拳，打的不是单点爆款，而是价格带的精准卡位。问界M5、M6、M7、M8、M9已覆盖不同细分市场，每一款都在自己的价格带里找位置。 赛力斯管理层近期有个表态值得琢磨：重点提升各车型的稳定销量贡献和经营效率。从“爆款驱动”转向“永续经营”，这话听起来平淡，但放在汽车行业里，是一道分水岭。爆款靠产品力爆发，永续经营靠体系化能力。赛力斯想走的，显然是后者。 70亿研发投入，安全数据是个观察窗口 底气从哪来？2026年上半年，赛力斯研发投入达70.07亿元，同比增长34.8%。这个数字放在车企财报里不算小。高强度研发投入，依托统一的平台化技术底座，在底层架构、核心系统、智能化体验上持续突破，最终会落到问界M6、M9这些主力车型的放量上。 说到技术，安全是个绕不开的观察窗口。赛力斯集团董事长张兴海说过：“没有安全，就没有其他；没有安全，努力都会清零。”问界暑期出行报告里有一组数据：辅助驾驶状态下，车辆平均在一次严重碰撞前已安全行驶1534万公里，是中国平均值的8.52倍；人驾状态下是625万公里，是中国平均值的3.47倍。 8.52倍是什么概念？是33.8亿公里真实行驶里程里跑出来的。以问界M9为例，720°安全保护架构、十三横十一纵车身结构、91%的铝合金及高强度钢占比，再加上全向防碰撞CAS5.0与40个传感器，从感知、决策到执行的主动安全链路被逐步打通。安全这件事，正在被销量数据反复验证。 从","listText":"金九银十的车市向来热闹，今年这份捷报值得一看——全新一代问界M9开启交付仅12周，累计交付突破30000台。 终端均价稳在60万元，持续位居50万级乘用车销量榜首。量价双优，放在当下的消费环境里，这个表现不算常见。 12周3万台，均价60万意味着什么？ 先看一组对比。问界M6累计交付突破5万台，售价22.98万元起；全新问界M9均价60万，12周破3万。一个往下扎，一个往上攻。赛力斯这套组合拳，打的不是单点爆款，而是价格带的精准卡位。问界M5、M6、M7、M8、M9已覆盖不同细分市场，每一款都在自己的价格带里找位置。 赛力斯管理层近期有个表态值得琢磨：重点提升各车型的稳定销量贡献和经营效率。从“爆款驱动”转向“永续经营”，这话听起来平淡，但放在汽车行业里，是一道分水岭。爆款靠产品力爆发，永续经营靠体系化能力。赛力斯想走的，显然是后者。 70亿研发投入，安全数据是个观察窗口 底气从哪来？2026年上半年，赛力斯研发投入达70.07亿元，同比增长34.8%。这个数字放在车企财报里不算小。高强度研发投入，依托统一的平台化技术底座，在底层架构、核心系统、智能化体验上持续突破，最终会落到问界M6、M9这些主力车型的放量上。 说到技术，安全是个绕不开的观察窗口。赛力斯集团董事长张兴海说过：“没有安全，就没有其他；没有安全，努力都会清零。”问界暑期出行报告里有一组数据：辅助驾驶状态下，车辆平均在一次严重碰撞前已安全行驶1534万公里，是中国平均值的8.52倍；人驾状态下是625万公里，是中国平均值的3.47倍。 8.52倍是什么概念？是33.8亿公里真实行驶里程里跑出来的。以问界M9为例，720°安全保护架构、十三横十一纵车身结构、91%的铝合金及高强度钢占比，再加上全向防碰撞CAS5.0与40个传感器，从感知、决策到执行的主动安全链路被逐步打通。安全这件事，正在被销量数据反复验证。 从","text":"金九银十的车市向来热闹，今年这份捷报值得一看——全新一代问界M9开启交付仅12周，累计交付突破30000台。 终端均价稳在60万元，持续位居50万级乘用车销量榜首。量价双优，放在当下的消费环境里，这个表现不算常见。 12周3万台，均价60万意味着什么？ 先看一组对比。问界M6累计交付突破5万台，售价22.98万元起；全新问界M9均价60万，12周破3万。一个往下扎，一个往上攻。赛力斯这套组合拳，打的不是单点爆款，而是价格带的精准卡位。问界M5、M6、M7、M8、M9已覆盖不同细分市场，每一款都在自己的价格带里找位置。 赛力斯管理层近期有个表态值得琢磨：重点提升各车型的稳定销量贡献和经营效率。从“爆款驱动”转向“永续经营”，这话听起来平淡，但放在汽车行业里，是一道分水岭。爆款靠产品力爆发，永续经营靠体系化能力。赛力斯想走的，显然是后者。 70亿研发投入，安全数据是个观察窗口 底气从哪来？2026年上半年，赛力斯研发投入达70.07亿元，同比增长34.8%。这个数字放在车企财报里不算小。高强度研发投入，依托统一的平台化技术底座，在底层架构、核心系统、智能化体验上持续突破，最终会落到问界M6、M9这些主力车型的放量上。 说到技术，安全是个绕不开的观察窗口。赛力斯集团董事长张兴海说过：“没有安全，就没有其他；没有安全，努力都会清零。”问界暑期出行报告里有一组数据：辅助驾驶状态下，车辆平均在一次严重碰撞前已安全行驶1534万公里，是中国平均值的8.52倍；人驾状态下是625万公里，是中国平均值的3.47倍。 8.52倍是什么概念？是33.8亿公里真实行驶里程里跑出来的。以问界M9为例，720°安全保护架构、十三横十一纵车身结构、91%的铝合金及高强度钢占比，再加上全向防碰撞CAS5.0与40个传感器，从感知、决策到执行的主动安全链路被逐步打通。安全这件事，正在被销量数据反复验证。 从","images":[{"img":"https://static.tigerbbs.com/e784e3703ab8a6eb831bfb435170dd7a","width":"618","height":"729"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606092755162496","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":586304642367752,"gmtCreate":1784172208354,"gmtModify":1784172210550,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"今天怎么也该给一个小小的安慰奖吧 <a href=\"https://laohu8.com/S/06880\">$MOMENTA-W(06880)$</a>","listText":"今天怎么也该给一个小小的安慰奖吧 <a href=\"https://laohu8.com/S/06880\">$MOMENTA-W(06880)$</a>","text":"今天怎么也该给一个小小的安慰奖吧 $MOMENTA-W(06880)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/586304642367752","isVote":1,"tweetType":1,"viewCount":719,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":573310804653888,"gmtCreate":1780990499168,"gmtModify":1780991277767,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"多款产品都在开拓海外市场，业务路子越走越宽，对长期发展是好事。<a target=\"_blank\" href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$ </a>","listText":"多款产品都在开拓海外市场，业务路子越走越宽，对长期发展是好事。<a target=\"_blank\" href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$ </a>","text":"多款产品都在开拓海外市场，业务路子越走越宽，对长期发展是好事。$迈威生物-B(02493)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/573310804653888","repostId":"573223407157424","repostType":1,"repost":{"id":573223407157424,"gmtCreate":1780982277538,"gmtModify":1780983367819,"author":{"id":"4143608060897040","authorId":"4143608060897040","name":"财小灶","avatar":"https://static.tigerbbs.com/f037add66dacb11d03924ffd57eee4b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4143608060897040","idStr":"4143608060897040"},"themes":[],"title":"迈威生物全球首个清除型抗体获批临床，用于治疗炎症性肠病（IBD）","htmlText":"2026年6月5日，迈威生物（688062.SH，02493.HK），一家全产业链布局的创新型生物制药公司，宣布其自主研发的抗体创新药 9MW5211 正式获得国家药品监督管理局（NMPA）批准，可针对炎症性肠病（IBD）开展临床试验。9MW5211 在其靶点上是全球首款进入临床阶段的候选药物。 9MW5211 是迈威生物自主研发的高度特异性的清除型创新抗体，可针对自身免疫性疾病中由异常免疫细胞介导的关键病理机制进行精准干预。免疫细胞的异常活化及组织浸润是多种自身免疫疾病发生发展的核心驱动因素。9MW5211 所靶向的分子在致病性免疫细胞表面特异性表达，是这些细胞异常活化的重要生物学标志。通过选择性识别并清除这群致病性细胞，9MW5211可有效阻断免疫级联反应，进而缓解疾病进展并改善临床症状。 经过多轮分子工程优化，9MW5211 展现出优异的靶点选择性，在实现高效阻断的同时，显著降低了非特异性结合风险，确保其对高表达靶点蛋白的致病性细胞实现深度清除。其独特的作用机制不仅有望带来更深层次的疾病缓解，也可能支持更长的给药间隔，从而提升患者治疗的依从性与生活质量。 临床前研究结果显示，9MW5211 在多种小鼠自身免疫疾病模型中均表现出显著的治疗潜力，未来临床应用有望涵盖多个大适应症。在食蟹猴模型中开展的安全性评估显示其具备良好的安全性特征。 此前，9MW5211 已获 FDA 许可在美国开展针对 IBD 的临床试验。其用于多发性硬化（MS）等多个适应症的临床试验申请已获 NMPA 受理，更多适应症的临床试验申请正在推进中。 <a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a> <a href=\"https://laohu8.com/U/20722186463466\">@爱发红包的虎妞</a>","listText":"2026年6月5日，迈威生物（688062.SH，02493.HK），一家全产业链布局的创新型生物制药公司，宣布其自主研发的抗体创新药 9MW5211 正式获得国家药品监督管理局（NMPA）批准，可针对炎症性肠病（IBD）开展临床试验。9MW5211 在其靶点上是全球首款进入临床阶段的候选药物。 9MW5211 是迈威生物自主研发的高度特异性的清除型创新抗体，可针对自身免疫性疾病中由异常免疫细胞介导的关键病理机制进行精准干预。免疫细胞的异常活化及组织浸润是多种自身免疫疾病发生发展的核心驱动因素。9MW5211 所靶向的分子在致病性免疫细胞表面特异性表达，是这些细胞异常活化的重要生物学标志。通过选择性识别并清除这群致病性细胞，9MW5211可有效阻断免疫级联反应，进而缓解疾病进展并改善临床症状。 经过多轮分子工程优化，9MW5211 展现出优异的靶点选择性，在实现高效阻断的同时，显著降低了非特异性结合风险，确保其对高表达靶点蛋白的致病性细胞实现深度清除。其独特的作用机制不仅有望带来更深层次的疾病缓解，也可能支持更长的给药间隔，从而提升患者治疗的依从性与生活质量。 临床前研究结果显示，9MW5211 在多种小鼠自身免疫疾病模型中均表现出显著的治疗潜力，未来临床应用有望涵盖多个大适应症。在食蟹猴模型中开展的安全性评估显示其具备良好的安全性特征。 此前，9MW5211 已获 FDA 许可在美国开展针对 IBD 的临床试验。其用于多发性硬化（MS）等多个适应症的临床试验申请已获 NMPA 受理，更多适应症的临床试验申请正在推进中。 <a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a> <a href=\"https://laohu8.com/U/20722186463466\">@爱发红包的虎妞</a>","text":"2026年6月5日，迈威生物（688062.SH，02493.HK），一家全产业链布局的创新型生物制药公司，宣布其自主研发的抗体创新药 9MW5211 正式获得国家药品监督管理局（NMPA）批准，可针对炎症性肠病（IBD）开展临床试验。9MW5211 在其靶点上是全球首款进入临床阶段的候选药物。 9MW5211 是迈威生物自主研发的高度特异性的清除型创新抗体，可针对自身免疫性疾病中由异常免疫细胞介导的关键病理机制进行精准干预。免疫细胞的异常活化及组织浸润是多种自身免疫疾病发生发展的核心驱动因素。9MW5211 所靶向的分子在致病性免疫细胞表面特异性表达，是这些细胞异常活化的重要生物学标志。通过选择性识别并清除这群致病性细胞，9MW5211可有效阻断免疫级联反应，进而缓解疾病进展并改善临床症状。 经过多轮分子工程优化，9MW5211 展现出优异的靶点选择性，在实现高效阻断的同时，显著降低了非特异性结合风险，确保其对高表达靶点蛋白的致病性细胞实现深度清除。其独特的作用机制不仅有望带来更深层次的疾病缓解，也可能支持更长的给药间隔，从而提升患者治疗的依从性与生活质量。 临床前研究结果显示，9MW5211 在多种小鼠自身免疫疾病模型中均表现出显著的治疗潜力，未来临床应用有望涵盖多个大适应症。在食蟹猴模型中开展的安全性评估显示其具备良好的安全性特征。 此前，9MW5211 已获 FDA 许可在美国开展针对 IBD 的临床试验。其用于多发性硬化（MS）等多个适应症的临床试验申请已获 NMPA 受理，更多适应症的临床试验申请正在推进中。 $迈威生物-B(02493)$ @爱发红包的虎妞","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/573223407157424","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":559090713179520,"gmtCreate":1777528465303,"gmtModify":1777528467419,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a>医药股蹲的就是管线的兑现。2821任何一个适应症报产，都是股价双击。我选择提前蹲，不等跑起来再追","listText":"<a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a>医药股蹲的就是管线的兑现。2821任何一个适应症报产，都是股价双击。我选择提前蹲，不等跑起来再追","text":"$迈威生物-B(02493)$医药股蹲的就是管线的兑现。2821任何一个适应症报产，都是股价双击。我选择提前蹲，不等跑起来再追","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/559090713179520","isVote":1,"tweetType":1,"viewCount":1707,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":559090487448008,"gmtCreate":1777528397094,"gmtModify":1777528399201,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/06656\">$思格新能(06656)$</a> 思格新能源上市才半个月，机构锁仓多，现在回调是洗盘，坚定看多，看到 750","listText":"<a href=\"https://laohu8.com/S/06656\">$思格新能(06656)$</a> 思格新能源上市才半个月，机构锁仓多，现在回调是洗盘，坚定看多，看到 750","text":"$思格新能(06656)$ 思格新能源上市才半个月，机构锁仓多，现在回调是洗盘，坚定看多，看到 750","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/559090487448008","isVote":1,"tweetType":1,"viewCount":1683,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":556264894424680,"gmtCreate":1776835373426,"gmtModify":1776835377610,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/06656\">$思格新能(06656)$</a> 分布式储能全球第一，市占率28.6%，思格新能源这是把细分赛道做到极致了，龙头溢价必须给","listText":"<a href=\"https://laohu8.com/S/06656\">$思格新能(06656)$</a> 分布式储能全球第一，市占率28.6%，思格新能源这是把细分赛道做到极致了，龙头溢价必须给","text":"$思格新能(06656)$ 分布式储能全球第一，市占率28.6%，思格新能源这是把细分赛道做到极致了，龙头溢价必须给","images":[{"img":"https://static.tigerbbs.com/36bfd6317a48c29875f78d8d38ee5bd7","width":"1080","height":"1080"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/556264894424680","isVote":1,"tweetType":1,"viewCount":1423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":543889718347192,"gmtCreate":1773811077672,"gmtModify":1773811080161,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00412\">$山高控股(00412)$</a>不懂为什么那么多人去追那些几百倍市盈率的氢能概念股。山高实打实投了好几个大的光伏电站和储能项目，现金流都是看得见的。按照机构给的可比公司估值，比如长江电力或者龙源电力那种逻辑，山高目前的市值远远没反映它手里的绿电资产。把它拆开卖都不止这个价。","listText":"<a href=\"https://laohu8.com/S/00412\">$山高控股(00412)$</a>不懂为什么那么多人去追那些几百倍市盈率的氢能概念股。山高实打实投了好几个大的光伏电站和储能项目，现金流都是看得见的。按照机构给的可比公司估值，比如长江电力或者龙源电力那种逻辑，山高目前的市值远远没反映它手里的绿电资产。把它拆开卖都不止这个价。","text":"$山高控股(00412)$不懂为什么那么多人去追那些几百倍市盈率的氢能概念股。山高实打实投了好几个大的光伏电站和储能项目，现金流都是看得见的。按照机构给的可比公司估值，比如长江电力或者龙源电力那种逻辑，山高目前的市值远远没反映它手里的绿电资产。把它拆开卖都不止这个价。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/543889718347192","isVote":1,"tweetType":1,"viewCount":1853,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":536076817994408,"gmtCreate":1771899014434,"gmtModify":1771899016346,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00100\">$MINIMAX-WP(00100)$</a> 中国AI行业从200多家卷到不到10家，MiniMax能活下来还被小摩增持，肯定有自己的硬实力。小摩说“MiniMax这么便宜，必须买进”，外界再怎么说，它在模型性能和商业化上的进展，都是实打实的","listText":"<a href=\"https://laohu8.com/S/00100\">$MINIMAX-WP(00100)$</a> 中国AI行业从200多家卷到不到10家，MiniMax能活下来还被小摩增持，肯定有自己的硬实力。小摩说“MiniMax这么便宜，必须买进”，外界再怎么说，它在模型性能和商业化上的进展，都是实打实的","text":"$MINIMAX-WP(00100)$ 中国AI行业从200多家卷到不到10家，MiniMax能活下来还被小摩增持，肯定有自己的硬实力。小摩说“MiniMax这么便宜，必须买进”，外界再怎么说，它在模型性能和商业化上的进展，都是实打实的","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/536076817994408","isVote":1,"tweetType":1,"viewCount":3504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":528667871019640,"gmtCreate":1770099870389,"gmtModify":1770099872845,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02718\">$明略科技-W(02718)$</a> 明略股价走势一路向上，看来资金都看好GEO这个AI营销新赛道的潜力","listText":"<a href=\"https://laohu8.com/S/02718\">$明略科技-W(02718)$</a> 明略股价走势一路向上，看来资金都看好GEO这个AI营销新赛道的潜力","text":"$明略科技-W(02718)$ 明略股价走势一路向上，看来资金都看好GEO这个AI营销新赛道的潜力","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/528667871019640","isVote":1,"tweetType":1,"viewCount":1975,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":528375366475848,"gmtCreate":1770018866483,"gmtModify":1770018868585,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/02677\">$卓正医疗(02677)$ </a>AI+医疗，腾讯系AI加持，何小鹏的跟注，金域医学也入局，前景还是不错的","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/02677\">$卓正医疗(02677)$ </a>AI+医疗，腾讯系AI加持，何小鹏的跟注，金域医学也入局，前景还是不错的","text":"$卓正医疗(02677)$ AI+医疗，腾讯系AI加持，何小鹏的跟注，金域医学也入局，前景还是不错的","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/528375366475848","repostId":"528341260199280","repostType":1,"repost":{"id":528341260199280,"gmtCreate":1770010527944,"gmtModify":1770011868770,"author":{"id":"4124841349957442","authorId":"4124841349957442","name":"舟木研究港美股","avatar":"https://static.tigerbbs.com/e834cef51d7c9c4365d8e12508be76f7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4124841349957442","idStr":"4124841349957442"},"themes":[],"title":"卓正医疗打新各方汇总","htmlText":"1.格隆汇：行业市销率估值5.1-6.0倍低于同行，营收复合年均增长率24.5%具备成长性，亏损收窄趋势明确，建议参与打新。 2.雪球：孖展超购85倍创年内医疗服务新股新高，散户参与热情充足，暗盘或上市首日易获得超额收益。 3.富途牛牛：流通盘仅3.12亿股，属于中小盘标的，叠加医疗服务与消费升级概念，炒作空间大于大盘股。 4.新XXX：32家门店覆盖广深等一线城市，高端客群粘性强，复购率65%，单店盈利模型跑通，长期发展价值可期。与固生堂业务模式相似，均为全科加专科布局，但估值更低，营收增速更高，存在估值修复空间。 5.打XXX：2023年经营现金流首次转正，现金储备4.2亿，财务风险偏低，适合稳健型打新投资者。 6.深圳XXX：概念一般但高端市场切入效果尚可，资本认可度较高，参考圣贝拉首日表现；设有绿鞋与基石投资，保荐人资质合格；方案B发行仅9500手，货量极少，中签率偏低，属于难中标的小票，只要及时离场，整体风险可控，需避免长期持有与加仓捞货。 7.石X：公司所处行业具备热度，市场地位、经营业绩与发展前景均具备优势，股东层面有腾讯加持，预计孖展认购热度较高；短板在于货量偏少，中签难度大，从打新性价比来看，或不及两支二次上市股票。 8.龙龟XX：当前市场二次上市股票较多，纯新股标的稀缺，公司基本面优质，估值定价合理，同时具备顶级资本背书，具备较高参与价值，中签与否是概率问题，积极申购是态度问题。 9.每日XXX：风险偏好较高的投资者可酌情参与，普通投资者建议保持谨慎。 打新策略：风险最小化+收益最大化 1.参与结论 建议参与打新，但需控制仓位、严守交易纪律。核心逻辑为估值处于行业中低位、孖展认购情绪高涨、营收成长确定性较强、腾讯资本背书、小盘筹码稀缺。考虑到货量稀缺，应积极参与申购，同时采用小额分散布局。 2.关键操作要点 •申购策略：方案B发行仅9500手，中签难度较","listText":"1.格隆汇：行业市销率估值5.1-6.0倍低于同行，营收复合年均增长率24.5%具备成长性，亏损收窄趋势明确，建议参与打新。 2.雪球：孖展超购85倍创年内医疗服务新股新高，散户参与热情充足，暗盘或上市首日易获得超额收益。 3.富途牛牛：流通盘仅3.12亿股，属于中小盘标的，叠加医疗服务与消费升级概念，炒作空间大于大盘股。 4.新XXX：32家门店覆盖广深等一线城市，高端客群粘性强，复购率65%，单店盈利模型跑通，长期发展价值可期。与固生堂业务模式相似，均为全科加专科布局，但估值更低，营收增速更高，存在估值修复空间。 5.打XXX：2023年经营现金流首次转正，现金储备4.2亿，财务风险偏低，适合稳健型打新投资者。 6.深圳XXX：概念一般但高端市场切入效果尚可，资本认可度较高，参考圣贝拉首日表现；设有绿鞋与基石投资，保荐人资质合格；方案B发行仅9500手，货量极少，中签率偏低，属于难中标的小票，只要及时离场，整体风险可控，需避免长期持有与加仓捞货。 7.石X：公司所处行业具备热度，市场地位、经营业绩与发展前景均具备优势，股东层面有腾讯加持，预计孖展认购热度较高；短板在于货量偏少，中签难度大，从打新性价比来看，或不及两支二次上市股票。 8.龙龟XX：当前市场二次上市股票较多，纯新股标的稀缺，公司基本面优质，估值定价合理，同时具备顶级资本背书，具备较高参与价值，中签与否是概率问题，积极申购是态度问题。 9.每日XXX：风险偏好较高的投资者可酌情参与，普通投资者建议保持谨慎。 打新策略：风险最小化+收益最大化 1.参与结论 建议参与打新，但需控制仓位、严守交易纪律。核心逻辑为估值处于行业中低位、孖展认购情绪高涨、营收成长确定性较强、腾讯资本背书、小盘筹码稀缺。考虑到货量稀缺，应积极参与申购，同时采用小额分散布局。 2.关键操作要点 •申购策略：方案B发行仅9500手，中签难度较","text":"1.格隆汇：行业市销率估值5.1-6.0倍低于同行，营收复合年均增长率24.5%具备成长性，亏损收窄趋势明确，建议参与打新。 2.雪球：孖展超购85倍创年内医疗服务新股新高，散户参与热情充足，暗盘或上市首日易获得超额收益。 3.富途牛牛：流通盘仅3.12亿股，属于中小盘标的，叠加医疗服务与消费升级概念，炒作空间大于大盘股。 4.新XXX：32家门店覆盖广深等一线城市，高端客群粘性强，复购率65%，单店盈利模型跑通，长期发展价值可期。与固生堂业务模式相似，均为全科加专科布局，但估值更低，营收增速更高，存在估值修复空间。 5.打XXX：2023年经营现金流首次转正，现金储备4.2亿，财务风险偏低，适合稳健型打新投资者。 6.深圳XXX：概念一般但高端市场切入效果尚可，资本认可度较高，参考圣贝拉首日表现；设有绿鞋与基石投资，保荐人资质合格；方案B发行仅9500手，货量极少，中签率偏低，属于难中标的小票，只要及时离场，整体风险可控，需避免长期持有与加仓捞货。 7.石X：公司所处行业具备热度，市场地位、经营业绩与发展前景均具备优势，股东层面有腾讯加持，预计孖展认购热度较高；短板在于货量偏少，中签难度大，从打新性价比来看，或不及两支二次上市股票。 8.龙龟XX：当前市场二次上市股票较多，纯新股标的稀缺，公司基本面优质，估值定价合理，同时具备顶级资本背书，具备较高参与价值，中签与否是概率问题，积极申购是态度问题。 9.每日XXX：风险偏好较高的投资者可酌情参与，普通投资者建议保持谨慎。 打新策略：风险最小化+收益最大化 1.参与结论 建议参与打新，但需控制仓位、严守交易纪律。核心逻辑为估值处于行业中低位、孖展认购情绪高涨、营收成长确定性较强、腾讯资本背书、小盘筹码稀缺。考虑到货量稀缺，应积极参与申购，同时采用小额分散布局。 2.关键操作要点 •申购策略：方案B发行仅9500手，中签难度较","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/528341260199280","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":520030514766328,"gmtCreate":1767936002599,"gmtModify":1767936004450,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 基石长期持有+入港股通 ，近期订单也是不断，入通前能上30","listText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 基石长期持有+入港股通 ，近期订单也是不断，入通前能上30","text":"$极智嘉-W(02590)$ 基石长期持有+入港股通 ，近期订单也是不断，入通前能上30","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/520030514766328","isVote":1,"tweetType":1,"viewCount":3873,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3572569667966603","authorId":"3572569667966603","name":"BENBENBEN","avatar":"https://static.tigerbbs.com/d9310aca6850a69947792b8faef3e872","crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"3572569667966603","idStr":"3572569667966603"},"content":"卖不完的货，稍微拉起来一点就大量卖盘","text":"卖不完的货，稍微拉起来一点就大量卖盘","html":"卖不完的货，稍微拉起来一点就大量卖盘"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":516548020113432,"gmtCreate":1767080200583,"gmtModify":1767080202870,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/300058\">$蓝色光标(300058)$</a> <a href=\"https://laohu8.com/S/002558\">$巨人网络(002558)$</a> 对于高速成长的企业来说，要区分“低效烧钱”与“高效投入下的阶段性亏损”。AI研发本身就具有高投入、长周期的特性，头部大厂尚且需要持续加码投入，对MiniMax这样的创新企业而言，早期亏损是技术积累的必然阶段。更值得关注的是，其在有限资金下验证的技术实力，已具备商业化落地的基础，这为后续盈利提供了可能性。 <a href=\"https://laohu8.com/S/300624\">$万兴科技(300624)$</a>","listText":"<a href=\"https://laohu8.com/S/300058\">$蓝色光标(300058)$</a> <a href=\"https://laohu8.com/S/002558\">$巨人网络(002558)$</a> 对于高速成长的企业来说，要区分“低效烧钱”与“高效投入下的阶段性亏损”。AI研发本身就具有高投入、长周期的特性，头部大厂尚且需要持续加码投入，对MiniMax这样的创新企业而言，早期亏损是技术积累的必然阶段。更值得关注的是，其在有限资金下验证的技术实力，已具备商业化落地的基础，这为后续盈利提供了可能性。 <a href=\"https://laohu8.com/S/300624\">$万兴科技(300624)$</a>","text":"$蓝色光标(300058)$ $巨人网络(002558)$ 对于高速成长的企业来说，要区分“低效烧钱”与“高效投入下的阶段性亏损”。AI研发本身就具有高投入、长周期的特性，头部大厂尚且需要持续加码投入，对MiniMax这样的创新企业而言，早期亏损是技术积累的必然阶段。更值得关注的是，其在有限资金下验证的技术实力，已具备商业化落地的基础，这为后续盈利提供了可能性。 $万兴科技(300624)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/516548020113432","isVote":1,"tweetType":1,"viewCount":3266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":512386419545216,"gmtCreate":1766121381079,"gmtModify":1766121382761,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/06896\">$金嗓子(06896)$</a> 大盘那么好，跟上节奏来","listText":"<a href=\"https://laohu8.com/S/06896\">$金嗓子(06896)$</a> 大盘那么好，跟上节奏来","text":"$金嗓子(06896)$ 大盘那么好，跟上节奏来","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/512386419545216","isVote":1,"tweetType":1,"viewCount":1647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":500983875453392,"gmtCreate":1763351200300,"gmtModify":1763351202208,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/601127\">$赛力斯(601127)$</a> 销量增长、新车型落地、技术合作落地三利好叠加，赛力斯的新车型周期和具身智能业务布局形成了良性呼应","listText":"<a href=\"https://laohu8.com/S/601127\">$赛力斯(601127)$</a> 销量增长、新车型落地、技术合作落地三利好叠加，赛力斯的新车型周期和具身智能业务布局形成了良性呼应","text":"$赛力斯(601127)$ 销量增长、新车型落地、技术合作落地三利好叠加，赛力斯的新车型周期和具身智能业务布局形成了良性呼应","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/500983875453392","isVote":1,"tweetType":1,"viewCount":3577,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4087984965265220","authorId":"4087984965265220","name":"西门小呆瓜cc","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4087984965265220","idStr":"4087984965265220"},"content":"自欺欺人，新能源这么卷，哪有那么多长线，真以为yy领先啊","text":"自欺欺人，新能源这么卷，哪有那么多长线，真以为yy领先啊","html":"自欺欺人，新能源这么卷，哪有那么多长线，真以为yy领先啊"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":492196162642272,"gmtCreate":1761186027904,"gmtModify":1761186029876,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/06896\">$金嗓子(06896)$</a>营收虽然下滑但毛利率逆势提升到77%，成本控制是真功夫","listText":"<a href=\"https://laohu8.com/S/06896\">$金嗓子(06896)$</a>营收虽然下滑但毛利率逆势提升到77%，成本控制是真功夫","text":"$金嗓子(06896)$营收虽然下滑但毛利率逆势提升到77%，成本控制是真功夫","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/492196162642272","isVote":1,"tweetType":1,"viewCount":1906,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":490045880562040,"gmtCreate":1760667041504,"gmtModify":1760667043160,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/06676\">$找钢集团-W(06676)$</a>听说有大型产业基金在悄悄吸货了？产业资本的眼睛是雪亮的，他们看的是五年后的格局","listText":"<a href=\"https://laohu8.com/S/06676\">$找钢集团-W(06676)$</a>听说有大型产业基金在悄悄吸货了？产业资本的眼睛是雪亮的，他们看的是五年后的格局","text":"$找钢集团-W(06676)$听说有大型产业基金在悄悄吸货了？产业资本的眼睛是雪亮的，他们看的是五年后的格局","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/490045880562040","isVote":1,"tweetType":1,"viewCount":1626,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":490044859540216,"gmtCreate":1760667012136,"gmtModify":1760667014171,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 大盘又暴跌了，港股这行情，也是没谁了啊","listText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 大盘又暴跌了，港股这行情，也是没谁了啊","text":"$极智嘉-W(02590)$ 大盘又暴跌了，港股这行情，也是没谁了啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/490044859540216","isVote":1,"tweetType":1,"viewCount":1430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":479899404808912,"gmtCreate":1758187206364,"gmtModify":1758187208559,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02525\">$禾赛-W(02525)$</a> <a href=\"https://laohu8.com/S/HSAI\">$禾赛(HSAI)$</a> 钛 7 四驱顶配车型搭载了天神之眼 B-辅助驾驶激光版，配备禾赛激光雷达和 Orin-X 芯片，支持高速 / 城市领航辅助以及泊车辅助等功能。业绩能见度很高，短线情绪可蹲。","listText":"<a href=\"https://laohu8.com/S/02525\">$禾赛-W(02525)$</a> <a href=\"https://laohu8.com/S/HSAI\">$禾赛(HSAI)$</a> 钛 7 四驱顶配车型搭载了天神之眼 B-辅助驾驶激光版，配备禾赛激光雷达和 Orin-X 芯片，支持高速 / 城市领航辅助以及泊车辅助等功能。业绩能见度很高，短线情绪可蹲。","text":"$禾赛-W(02525)$ $禾赛(HSAI)$ 钛 7 四驱顶配车型搭载了天神之眼 B-辅助驾驶激光版，配备禾赛激光雷达和 Orin-X 芯片，支持高速 / 城市领航辅助以及泊车辅助等功能。业绩能见度很高，短线情绪可蹲。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/479899404808912","isVote":1,"tweetType":1,"viewCount":2103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":471289365037616,"gmtCreate":1756092466174,"gmtModify":1756093515269,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"全球第五大空调提供商，前景还是不错的。","listText":"全球第五大空调提供商，前景还是不错的。","text":"全球第五大空调提供商，前景还是不错的。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/471289365037616","repostId":"471282722938984","repostType":1,"repost":{"id":471282722938984,"gmtCreate":1756090783020,"gmtModify":1756091147773,"author":{"id":"3575272506103176","authorId":"3575272506103176","name":"投行小師弟","avatar":"https://static.tigerbbs.com/cbaef50e1a36058616ca717b01b65c25","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3575272506103176","idStr":"3575272506103176"},"themes":[],"title":"奥克斯电气今起招股 预计将于9月2日开始在联交所买卖","htmlText":"8月25日早间，奥克斯电气发布公告，公司拟全球发售约2.07亿股股份(视乎发售量调整权及超额配股权行使与否而定)，中国香港发售股份1035.82万股，国际发售股份约1.97亿股。 将自2025年8月25日至8月28日招股，预期定价日为8月29日；发售价将为每股发售股份16.00-17.42港元，每手买卖单位为200股，为独家保荐人；预期股份将于2025年9月2日开始在联交所买卖。 过往报道，7月16日，港交所文件显示，奥克斯电气有限公司向港交所提交上市申请书，中金公司为独家保荐人。 招股书披露，该公司是全球前五大空调提供商之一，集家用和中央空调设计、研发、生产、销售及服务于一体。根据弗若斯特沙利文的资料，于2024年，按销量计算，奥克斯电气是全球第五大空调提供商，市场份额达7.1%。 于业绩记录期内，奥克斯电气的收入由2022年的人民币19,527.6百万元增加27.2%至2023年的人民币24,831.8百万元，并进一步增加19.8%至2024年的人民币29,759.3百万元。此外，其收入由截至2024年3月31日止三个月的人民币7,362.6百万元增加27.0%至截至2025年3月31日止三个月的人民币9,352.4百万元。 <a href=\"https://laohu8.com/S/02580\">$奥克斯电气(02580)$</a> <a href=\"https://laohu8.com/U/20722186463466\">@爱发红包的虎妞</a> <a href=\"https://laohu8.com/U/36984908995200\">@小虎活动</a>","listText":"8月25日早间，奥克斯电气发布公告，公司拟全球发售约2.07亿股股份(视乎发售量调整权及超额配股权行使与否而定)，中国香港发售股份1035.82万股，国际发售股份约1.97亿股。 将自2025年8月25日至8月28日招股，预期定价日为8月29日；发售价将为每股发售股份16.00-17.42港元，每手买卖单位为200股，为独家保荐人；预期股份将于2025年9月2日开始在联交所买卖。 过往报道，7月16日，港交所文件显示，奥克斯电气有限公司向港交所提交上市申请书，中金公司为独家保荐人。 招股书披露，该公司是全球前五大空调提供商之一，集家用和中央空调设计、研发、生产、销售及服务于一体。根据弗若斯特沙利文的资料，于2024年，按销量计算，奥克斯电气是全球第五大空调提供商，市场份额达7.1%。 于业绩记录期内，奥克斯电气的收入由2022年的人民币19,527.6百万元增加27.2%至2023年的人民币24,831.8百万元，并进一步增加19.8%至2024年的人民币29,759.3百万元。此外，其收入由截至2024年3月31日止三个月的人民币7,362.6百万元增加27.0%至截至2025年3月31日止三个月的人民币9,352.4百万元。 <a href=\"https://laohu8.com/S/02580\">$奥克斯电气(02580)$</a> <a href=\"https://laohu8.com/U/20722186463466\">@爱发红包的虎妞</a> <a href=\"https://laohu8.com/U/36984908995200\">@小虎活动</a>","text":"8月25日早间，奥克斯电气发布公告，公司拟全球发售约2.07亿股股份(视乎发售量调整权及超额配股权行使与否而定)，中国香港发售股份1035.82万股，国际发售股份约1.97亿股。 将自2025年8月25日至8月28日招股，预期定价日为8月29日；发售价将为每股发售股份16.00-17.42港元，每手买卖单位为200股，为独家保荐人；预期股份将于2025年9月2日开始在联交所买卖。 过往报道，7月16日，港交所文件显示，奥克斯电气有限公司向港交所提交上市申请书，中金公司为独家保荐人。 招股书披露，该公司是全球前五大空调提供商之一，集家用和中央空调设计、研发、生产、销售及服务于一体。根据弗若斯特沙利文的资料，于2024年，按销量计算，奥克斯电气是全球第五大空调提供商，市场份额达7.1%。 于业绩记录期内，奥克斯电气的收入由2022年的人民币19,527.6百万元增加27.2%至2023年的人民币24,831.8百万元，并进一步增加19.8%至2024年的人民币29,759.3百万元。此外，其收入由截至2024年3月31日止三个月的人民币7,362.6百万元增加27.0%至截至2025年3月31日止三个月的人民币9,352.4百万元。 $奥克斯电气(02580)$ @爱发红包的虎妞 @小虎活动","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/471282722938984","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":559090713179520,"gmtCreate":1777528465303,"gmtModify":1777528467419,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a>医药股蹲的就是管线的兑现。2821任何一个适应症报产，都是股价双击。我选择提前蹲，不等跑起来再追","listText":"<a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a>医药股蹲的就是管线的兑现。2821任何一个适应症报产，都是股价双击。我选择提前蹲，不等跑起来再追","text":"$迈威生物-B(02493)$医药股蹲的就是管线的兑现。2821任何一个适应症报产，都是股价双击。我选择提前蹲，不等跑起来再追","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/559090713179520","isVote":1,"tweetType":1,"viewCount":1707,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":520030514766328,"gmtCreate":1767936002599,"gmtModify":1767936004450,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 基石长期持有+入港股通 ，近期订单也是不断，入通前能上30","listText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 基石长期持有+入港股通 ，近期订单也是不断，入通前能上30","text":"$极智嘉-W(02590)$ 基石长期持有+入港股通 ，近期订单也是不断，入通前能上30","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/520030514766328","isVote":1,"tweetType":1,"viewCount":3873,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3572569667966603","authorId":"3572569667966603","name":"BENBENBEN","avatar":"https://static.tigerbbs.com/d9310aca6850a69947792b8faef3e872","crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"3572569667966603","idStr":"3572569667966603"},"content":"卖不完的货，稍微拉起来一点就大量卖盘","text":"卖不完的货，稍微拉起来一点就大量卖盘","html":"卖不完的货，稍微拉起来一点就大量卖盘"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":610428710101032,"gmtCreate":1790057211699,"gmtModify":1790057213980,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"我思路跟大伙不太一样，发布会、技术参数我都懒得细扒。我就看价格。早先800V高压，基本二十万起步。现在银河十几万就能拿下。这就好比以前高档餐厅的招牌菜，如今放到家常菜馆卖<a href=\"https://laohu8.com/S/00175\">$吉利汽车(00175)$</a>","listText":"我思路跟大伙不太一样，发布会、技术参数我都懒得细扒。我就看价格。早先800V高压，基本二十万起步。现在银河十几万就能拿下。这就好比以前高档餐厅的招牌菜，如今放到家常菜馆卖<a href=\"https://laohu8.com/S/00175\">$吉利汽车(00175)$</a>","text":"我思路跟大伙不太一样，发布会、技术参数我都懒得细扒。我就看价格。早先800V高压，基本二十万起步。现在银河十几万就能拿下。这就好比以前高档餐厅的招牌菜，如今放到家常菜馆卖$吉利汽车(00175)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/610428710101032","isVote":1,"tweetType":1,"viewCount":1199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":500983875453392,"gmtCreate":1763351200300,"gmtModify":1763351202208,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/601127\">$赛力斯(601127)$</a> 销量增长、新车型落地、技术合作落地三利好叠加，赛力斯的新车型周期和具身智能业务布局形成了良性呼应","listText":"<a href=\"https://laohu8.com/S/601127\">$赛力斯(601127)$</a> 销量增长、新车型落地、技术合作落地三利好叠加，赛力斯的新车型周期和具身智能业务布局形成了良性呼应","text":"$赛力斯(601127)$ 销量增长、新车型落地、技术合作落地三利好叠加，赛力斯的新车型周期和具身智能业务布局形成了良性呼应","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/500983875453392","isVote":1,"tweetType":1,"viewCount":3577,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4087984965265220","authorId":"4087984965265220","name":"西门小呆瓜cc","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4087984965265220","idStr":"4087984965265220"},"content":"自欺欺人，新能源这么卷，哪有那么多长线，真以为yy领先啊","text":"自欺欺人，新能源这么卷，哪有那么多长线，真以为yy领先啊","html":"自欺欺人，新能源这么卷，哪有那么多长线，真以为yy领先啊"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":573310804653888,"gmtCreate":1780990499168,"gmtModify":1780991277767,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"多款产品都在开拓海外市场，业务路子越走越宽，对长期发展是好事。<a target=\"_blank\" href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$ </a>","listText":"多款产品都在开拓海外市场，业务路子越走越宽，对长期发展是好事。<a target=\"_blank\" href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$ </a>","text":"多款产品都在开拓海外市场，业务路子越走越宽，对长期发展是好事。$迈威生物-B(02493)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/573310804653888","repostId":"573223407157424","repostType":1,"repost":{"id":573223407157424,"gmtCreate":1780982277538,"gmtModify":1780983367819,"author":{"id":"4143608060897040","authorId":"4143608060897040","name":"财小灶","avatar":"https://static.tigerbbs.com/f037add66dacb11d03924ffd57eee4b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4143608060897040","idStr":"4143608060897040"},"themes":[],"title":"迈威生物全球首个清除型抗体获批临床，用于治疗炎症性肠病（IBD）","htmlText":"2026年6月5日，迈威生物（688062.SH，02493.HK），一家全产业链布局的创新型生物制药公司，宣布其自主研发的抗体创新药 9MW5211 正式获得国家药品监督管理局（NMPA）批准，可针对炎症性肠病（IBD）开展临床试验。9MW5211 在其靶点上是全球首款进入临床阶段的候选药物。 9MW5211 是迈威生物自主研发的高度特异性的清除型创新抗体，可针对自身免疫性疾病中由异常免疫细胞介导的关键病理机制进行精准干预。免疫细胞的异常活化及组织浸润是多种自身免疫疾病发生发展的核心驱动因素。9MW5211 所靶向的分子在致病性免疫细胞表面特异性表达，是这些细胞异常活化的重要生物学标志。通过选择性识别并清除这群致病性细胞，9MW5211可有效阻断免疫级联反应，进而缓解疾病进展并改善临床症状。 经过多轮分子工程优化，9MW5211 展现出优异的靶点选择性，在实现高效阻断的同时，显著降低了非特异性结合风险，确保其对高表达靶点蛋白的致病性细胞实现深度清除。其独特的作用机制不仅有望带来更深层次的疾病缓解，也可能支持更长的给药间隔，从而提升患者治疗的依从性与生活质量。 临床前研究结果显示，9MW5211 在多种小鼠自身免疫疾病模型中均表现出显著的治疗潜力，未来临床应用有望涵盖多个大适应症。在食蟹猴模型中开展的安全性评估显示其具备良好的安全性特征。 此前，9MW5211 已获 FDA 许可在美国开展针对 IBD 的临床试验。其用于多发性硬化（MS）等多个适应症的临床试验申请已获 NMPA 受理，更多适应症的临床试验申请正在推进中。 <a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a> <a href=\"https://laohu8.com/U/20722186463466\">@爱发红包的虎妞</a>","listText":"2026年6月5日，迈威生物（688062.SH，02493.HK），一家全产业链布局的创新型生物制药公司，宣布其自主研发的抗体创新药 9MW5211 正式获得国家药品监督管理局（NMPA）批准，可针对炎症性肠病（IBD）开展临床试验。9MW5211 在其靶点上是全球首款进入临床阶段的候选药物。 9MW5211 是迈威生物自主研发的高度特异性的清除型创新抗体，可针对自身免疫性疾病中由异常免疫细胞介导的关键病理机制进行精准干预。免疫细胞的异常活化及组织浸润是多种自身免疫疾病发生发展的核心驱动因素。9MW5211 所靶向的分子在致病性免疫细胞表面特异性表达，是这些细胞异常活化的重要生物学标志。通过选择性识别并清除这群致病性细胞，9MW5211可有效阻断免疫级联反应，进而缓解疾病进展并改善临床症状。 经过多轮分子工程优化，9MW5211 展现出优异的靶点选择性，在实现高效阻断的同时，显著降低了非特异性结合风险，确保其对高表达靶点蛋白的致病性细胞实现深度清除。其独特的作用机制不仅有望带来更深层次的疾病缓解，也可能支持更长的给药间隔，从而提升患者治疗的依从性与生活质量。 临床前研究结果显示，9MW5211 在多种小鼠自身免疫疾病模型中均表现出显著的治疗潜力，未来临床应用有望涵盖多个大适应症。在食蟹猴模型中开展的安全性评估显示其具备良好的安全性特征。 此前，9MW5211 已获 FDA 许可在美国开展针对 IBD 的临床试验。其用于多发性硬化（MS）等多个适应症的临床试验申请已获 NMPA 受理，更多适应症的临床试验申请正在推进中。 <a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a> <a href=\"https://laohu8.com/U/20722186463466\">@爱发红包的虎妞</a>","text":"2026年6月5日，迈威生物（688062.SH，02493.HK），一家全产业链布局的创新型生物制药公司，宣布其自主研发的抗体创新药 9MW5211 正式获得国家药品监督管理局（NMPA）批准，可针对炎症性肠病（IBD）开展临床试验。9MW5211 在其靶点上是全球首款进入临床阶段的候选药物。 9MW5211 是迈威生物自主研发的高度特异性的清除型创新抗体，可针对自身免疫性疾病中由异常免疫细胞介导的关键病理机制进行精准干预。免疫细胞的异常活化及组织浸润是多种自身免疫疾病发生发展的核心驱动因素。9MW5211 所靶向的分子在致病性免疫细胞表面特异性表达，是这些细胞异常活化的重要生物学标志。通过选择性识别并清除这群致病性细胞，9MW5211可有效阻断免疫级联反应，进而缓解疾病进展并改善临床症状。 经过多轮分子工程优化，9MW5211 展现出优异的靶点选择性，在实现高效阻断的同时，显著降低了非特异性结合风险，确保其对高表达靶点蛋白的致病性细胞实现深度清除。其独特的作用机制不仅有望带来更深层次的疾病缓解，也可能支持更长的给药间隔，从而提升患者治疗的依从性与生活质量。 临床前研究结果显示，9MW5211 在多种小鼠自身免疫疾病模型中均表现出显著的治疗潜力，未来临床应用有望涵盖多个大适应症。在食蟹猴模型中开展的安全性评估显示其具备良好的安全性特征。 此前，9MW5211 已获 FDA 许可在美国开展针对 IBD 的临床试验。其用于多发性硬化（MS）等多个适应症的临床试验申请已获 NMPA 受理，更多适应症的临床试验申请正在推进中。 $迈威生物-B(02493)$ @爱发红包的虎妞","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/573223407157424","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":559090487448008,"gmtCreate":1777528397094,"gmtModify":1777528399201,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/06656\">$思格新能(06656)$</a> 思格新能源上市才半个月，机构锁仓多，现在回调是洗盘，坚定看多，看到 750","listText":"<a href=\"https://laohu8.com/S/06656\">$思格新能(06656)$</a> 思格新能源上市才半个月，机构锁仓多，现在回调是洗盘，坚定看多，看到 750","text":"$思格新能(06656)$ 思格新能源上市才半个月，机构锁仓多，现在回调是洗盘，坚定看多，看到 750","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/559090487448008","isVote":1,"tweetType":1,"viewCount":1683,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":556264894424680,"gmtCreate":1776835373426,"gmtModify":1776835377610,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/06656\">$思格新能(06656)$</a> 分布式储能全球第一，市占率28.6%，思格新能源这是把细分赛道做到极致了，龙头溢价必须给","listText":"<a href=\"https://laohu8.com/S/06656\">$思格新能(06656)$</a> 分布式储能全球第一，市占率28.6%，思格新能源这是把细分赛道做到极致了，龙头溢价必须给","text":"$思格新能(06656)$ 分布式储能全球第一，市占率28.6%，思格新能源这是把细分赛道做到极致了，龙头溢价必须给","images":[{"img":"https://static.tigerbbs.com/36bfd6317a48c29875f78d8d38ee5bd7","width":"1080","height":"1080"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/556264894424680","isVote":1,"tweetType":1,"viewCount":1423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":543889718347192,"gmtCreate":1773811077672,"gmtModify":1773811080161,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00412\">$山高控股(00412)$</a>不懂为什么那么多人去追那些几百倍市盈率的氢能概念股。山高实打实投了好几个大的光伏电站和储能项目，现金流都是看得见的。按照机构给的可比公司估值，比如长江电力或者龙源电力那种逻辑，山高目前的市值远远没反映它手里的绿电资产。把它拆开卖都不止这个价。","listText":"<a href=\"https://laohu8.com/S/00412\">$山高控股(00412)$</a>不懂为什么那么多人去追那些几百倍市盈率的氢能概念股。山高实打实投了好几个大的光伏电站和储能项目，现金流都是看得见的。按照机构给的可比公司估值，比如长江电力或者龙源电力那种逻辑，山高目前的市值远远没反映它手里的绿电资产。把它拆开卖都不止这个价。","text":"$山高控股(00412)$不懂为什么那么多人去追那些几百倍市盈率的氢能概念股。山高实打实投了好几个大的光伏电站和储能项目，现金流都是看得见的。按照机构给的可比公司估值，比如长江电力或者龙源电力那种逻辑，山高目前的市值远远没反映它手里的绿电资产。把它拆开卖都不止这个价。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/543889718347192","isVote":1,"tweetType":1,"viewCount":1853,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":536076817994408,"gmtCreate":1771899014434,"gmtModify":1771899016346,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00100\">$MINIMAX-WP(00100)$</a> 中国AI行业从200多家卷到不到10家，MiniMax能活下来还被小摩增持，肯定有自己的硬实力。小摩说“MiniMax这么便宜，必须买进”，外界再怎么说，它在模型性能和商业化上的进展，都是实打实的","listText":"<a href=\"https://laohu8.com/S/00100\">$MINIMAX-WP(00100)$</a> 中国AI行业从200多家卷到不到10家，MiniMax能活下来还被小摩增持，肯定有自己的硬实力。小摩说“MiniMax这么便宜，必须买进”，外界再怎么说，它在模型性能和商业化上的进展，都是实打实的","text":"$MINIMAX-WP(00100)$ 中国AI行业从200多家卷到不到10家，MiniMax能活下来还被小摩增持，肯定有自己的硬实力。小摩说“MiniMax这么便宜，必须买进”，外界再怎么说，它在模型性能和商业化上的进展，都是实打实的","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/536076817994408","isVote":1,"tweetType":1,"viewCount":3504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":528667871019640,"gmtCreate":1770099870389,"gmtModify":1770099872845,"author":{"id":"4215313328797350","authorId":"4215313328797350","name":"小打小闹心平气和","avatar":"https://static.tigerbbs.com/dbbc042a81c93b6ac25fa8c1622b7972","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4215313328797350","idStr":"4215313328797350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02718\">$明略科技-W(02718)$</a> 明略股价走势一路向上，看来资金都看好GEO这个AI营销新赛道的潜力","listText":"<a href=\"https://laohu8.com/S/02718\">$明略科技-W(02718)$</a> 明略股价走势一路向上，看来资金都看好GEO这个AI营销新赛道的潜力","text":"$明略科技-W(02718)$ 明略股价走势一路向上，看来资金都看好GEO这个AI营销新赛道的潜力","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/528667871019640","isVote":1,"tweetType":1,"viewCount":1975,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}